Projects Funded

ACCOMPLISHMENTS TO DATE

From February 2001 to December 2016, The Morgan Adams Foundation has funded over $4,000,000 in research funds for pilot, seed and translational studies.

INSTITUTIONAL PARTNERS

Children's Hospital Colorado

POETIC

Memorial Sloan Kettering Cancer Center - New York, NY

University of North Carolina, Chapel Hill - Chapel Hill, NC

MD Anderson - Houston TX

Johns Hopkins - Baltimore, MD

Children's Mercy Hospital - Kansas City, KS

Alberta Children's Hospital - Calgary, Alberta, Canada

The Hospital for Sick Kids (Sick Kids) - Toronto, Ontario, Canada

2016 PROJECTS - FUNDED 

  • PI: Nicholas Foreman, Andrew Donson, Rajeev Vibhakar
    Chipping “in the round.” Extension of tumor characterization to include mutation and epigenetic profiling as well as mRNA expression
    Funded in part by Grace’s Race
  • PIs: Andrew Donson, Nick Foreman, Rajeev Vibhakar
    RNASeq Transition: Creation of a pediatric brain tumor RNAseq reference database
  • PIs: Nick Foreman & Anandani Nellan
    Developing CAR T-Cell therapy for Pediatric Brain Tumors
  • PI: Rajeev Vibhakar, Krishna Madhavan
    Clinical model to investigate nanoparticle-mediated brain drug delivery
  • PI: Sujatha Venkataraman, Rajeev Vibhakar
    To Establish a new genome-editing technology called CRISPR-Cas9 as a means to generate pediatric brain tumor models carrying deletion or insertion of genes in a highly efficient manner.
    in partnership with The Adam Crocker Fund for Cancer Research
  • PI: Jean Mulcahy-Levy
    Cancer Stem Cell Influences in the setting of BRAF Mutations
  • PI: Adam Green
    Transcriptome Analysis of Recurrent Pediatric High Grade Gliomas
  • PI: Todd Hankinson, JP Martinez-Barbera
    Pre-Clinical Trial of Anti-Inflammatory Monoclonal Antibodies in a model of Adamantinomatous Craniopharyngioma
  • PI: JP Martinez-Barbera, Todd Hankinson
    Pre-Clinical Trial of Anti-Inflammatory Monoclonal Antibodies in a model of Adamantinomatous Craniopharyngioma
    Funding directed to University College of London
  • PI: Sujatha Venkataraman, Rajeev Vibhakar
    To investigate whether PTC-209, a small-molecule inhibitor of BMI-1, can potentiate DIPG cell killing by radiation: in-vitro and in-vivo study

*For a historical list of all projects funded, please contact Robin.